Insights from Digital Pharma Leaders
Refine Search
Pharmaceutical
A newly-published randomized controlled trial (RCT) has demonstrated that Deprexis, a digital therapeutic for depression with already extensive clinical validation, shows enhanced effectiveness when used alongside transcranial infrared laser stimulation (TILS). 25 March 2025
Pharmaceutical
Precision medicine has advanced significantly over the past decade, driven by breakthroughs in chemical, hardware, software, and especially cloud computing technologies. 18 March 2025
Biotechnology
MeiraGTx has entered into a strategic partnership with artificial intelligence firm Hologen to accelerate the Phase III development of AAV-GAD, a gene therapy for Parkinson’s disease. 13 March 2025
Pharmaceutical
Insilico Medicine has raised $110 million in a series E funding round to drive the development of its artificial intelligence-powered drug candidates, including its leading drug for idiopathic pulmonary fibrosis (IPF). 13 March 2025
Pharmaceutical
Germany’s Boehringer Ingelheim has launched the One Medicine Platform, a new system designed to streamline drug development, following the implementation of Veeva Systems' Development Cloud. 12 March 2025
Biotechnology
Nona Biosciences has introduced Hu-mAtrIx, an AI-assisted drug discovery platform designed to accelerate the identification and development of antibody-based therapies. 7 March 2025
Pharmaceutical
The new US President has repealed an executive order from October 2023, signed by the Biden administration, that sought to establish rigorous safeguards for artificial intelligence (AI) development. 22 February 2025
Pharmaceutical
US biopharma Incyte and privately-held AI-focused biotech Genesis Therapeutics have entered into a strategic collaboration focused on the research, discovery and development of novel small molecule medicines. 21 February 2025
Pharmaceutical
An Expert View from Kevin Wild, head of pre-sales at software company Syniti. 23 January 2025
Pharmaceutical
French pharmaceutical company Servier and Google Cloud have announced an expanded five-year partnership aimed at leveraging artificial intelligence (AI) and generative AI to accelerate drug research and development. 16 January 2025
Pharmaceutical
A collection of some of the largest US health systems, in collaboration with the Regeneron Genetics Center, have announced the launch of the Truveta Genome Project. 16 January 2025
Pharmaceutical
Privately-held Italian drugmaker Menarini and its oncology-focused subsidiary Stemline Therapeutics have entered into a licensing deal with AI-driven biotech Insilico Medicines. 15 January 2025
Biotechnology
Dyno Therapeutics, a privately-held US genetic technologies company applying AI to enable in vivo gene delivery, has announced that Roche has exercised its option to license a novel capsid for use in a gene therapy program for an undisclosed neurological disease indication. 13 January 2025
Pharmaceutical
Real-world evidence (RWE) specialist Atropos Health has announced a collaboration with US pharma giant Merck & Co. 13 January 2025
Biotechnology
Belgian biopharmaceutical company UCB has entered into a license agreement with Ailux Biologics, the biologics discovery division of XtalPi, to leverage its AI platform. 9 January 2025
Pharmaceutical
Insilico Medicine, a biotechnology firm specializing in artificial intelligence-powered drug discovery, has raised over $100 million in a series E funding round. 8 January 2025
Pharmaceutical
A team of Chinese researchers has identified a promising candidate for glaucoma treatment using artificial intelligence tools. 6 January 2025
Pharmaceutical
The market for artificial intelligence (AI) in cancer care is projected to grow from $2.2 billion in 2024 to $6.3 billion by 2029, reflecting a growth rate of 23.1%, according to a recent study by BCC Research. 31 December 2024
Biotechnology
AI-driven biotech BenevolentAI has announced sweeping changes aimed at refocusing its operations and extending its financial runway into 2027. 20 December 2024
Pharmaceutical
Shanghai-based Fangzhou, has entered into a strategic partnership with the Chinese business of Bristol Myers Squibb China, with the goal of enhancing digital platforms for chronic disease management. 19 December 2024
Pharmaceutical
The dramatic availability of new data sources along with the opportunity to leverage existing data pools, is radically changing the way we think about clinical trials, writes Mike Capone, chief operating officer of Medidata, the provider of cloud-based solutions for clinical research, in an Expert View piece. 14 June 2017
Pharmaceutical
In this week's Expert View, Gijs Hubben considers the role of value communication in facilitating market access for new pharmaceuticals, distilling his experience into three key recommendations for engagement with payers and providers.
Dr Hubben is chief executive and co-founder of software company BaseCase. Since 2007, he has partnered with life science companies to develop value communication tools using his company's proprietary customer engagement platform. 17 April 2017
Pharmaceutical
Billing itself as the first group backed by multiple big pharma which seeks to set technology standards to make it faster and easier for healthcare professionals (HCPs) to connect with the life sciences industry, Align Biopharma is now up and running. 10 April 2017
Pharmaceutical
As the life sciences industry seeks to improve customer engagements through personalized multichannel communications, the need for quality customer data is greater than ever, writes Guillaume Roussel, director of strategy for Veeva Open Data, Europe, part of the life sciences software provider Veeva Systems, in an expert view piece. 4 April 2017
Pharmaceutical
Sanofi and software designer Voluntis have announced a global alliance to deliver digital insulin titration solutions featuring a mobile phone application for type 2 diabetes patients treated with basal insulin to help with self-management and enable remote monitoring by healthcare teams. 15 March 2017
Pharmaceutical
In an expert view piece, Dana Shears, eMDI business development director of H&T Presspart and Melissa Manice, chief executive and co-founder of Cohero Health, look at how advances in mobile health and connected devices are opening up unprecedented opportunities in the management of chronic diseases. 7 March 2017
Pharmaceutical
According to Public Health England’s Annual Flu Report, there have been more than three million deaths in the UK since 2006 from flu. In an expert view piece, Nick Hawkins, managing director for EMEA at global mass notifications software provider Everbridge, shows how mass notification solutions can be used to stop the death toll rising. 15 February 2017
Pharmaceutical
CNS specialist Lundbeck has become the latest pharma company to announce a collaboration with IBM Watson Health. 25 January 2017
Pharmaceutical
Veeva System and six of the top 25 largest global pharmaceutical companies today announced the formation of Align Biopharma, a new group dedicated to setting technology standards that will make it faster and easier for healthcare professionals (HCPs) to connect with the life sciences industry. 11 January 2017
Pharmaceutical
It is no longer a question of if a digital revolution will happen in health care. 1 December 2016
Pharmaceutical
In our weekly expert view piece, pharmacovigilance team leader at Berlin-based CRO, KCR, examines the increasing benefits of post-authorization studies and the collection of real-world data. 14 September 2016
Pharmaceutical
Cases of meningitis B dropped by 50% in the UK during the first 10 months of the world’s first national immunization program using GlaxoSmithKline’s Bexsero. 7 September 2016
Pharmaceutical
An exponential growth in the global digital health market is giving pharma and life science companies a clear opportunity to play a greater role in delivering improved patient experiences, better clinical outcomes and cost-savings. 18 April 2016
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze